Hans-Jürgen Stark

Title: The Innovations of Hans-Jürgen Stark

Introduction

Hans-Jürgen Stark is a notable inventor based in Meckesheim, Germany. He has made significant contributions to the field of biomaterials, particularly in the context of anti-angiogenic therapy for tumor treatment. His work focuses on the use of hyaluronic acid derivatives in medical applications.

Latest Patents

Hans-Jürgen Stark holds a patent for "Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumors." This patent discloses the use of biomaterials based on hyaluronic acid derivatives, optionally in association with natural, synthetic, or semisynthetic biopolymers, to suppress the angiogenic process associated with tumor proliferation in both primary and secondary tumors. He has 1 patent to his name.

Career Highlights

Throughout his career, Stark has worked with prominent organizations, including Fidia Farmaceutici S.p.a. and Deutsches Krebsforschungszentrum. His experience in these institutions has allowed him to advance his research and contribute to the medical field significantly.

Collaborations

Some of his notable coworkers include Norbert Fusenig and Michael Willhauck. Their collaboration has likely enriched the research environment and fostered innovative ideas in their respective fields.

Conclusion

Hans-Jürgen Stark's contributions to biomaterials and anti-angiogenic therapy highlight his role as an influential inventor in the medical field. His work continues to impact the treatment of tumors and showcases the importance of innovation in healthcare.